本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cidara Therapeutics, Inc.

221.38
0.0000
成交量:- -
成交额:- -
市值:69.60亿
市盈率:-19.73
高:221.38
开:221.38
低:221.38
收:221.38
52周最高:221.42
52周最低:15.22
股本:3,143.94万
流通股本:2,486.62万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-11.2200
每股收益(LYR):-26.7460
净资产收益率:-68.70%
总资产收益率:-29.35%
市净率:16.48
市盈率(LYR):-8.28

数据加载中...

2024/12/05

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/12/04

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/26

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/26

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/23

重要事件披露

Form 8-K - Current report
2024/09/12

重要事件披露

Form 8-K - Current report
2024/08/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/07/30

SEC问询函

Form CORRESP - Correspondence
2024/07/29

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/29

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/26

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/07/19

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/07/18

重要事件披露

Form 8-K - Current report
2024/05/20

重要事件披露

Form 8-K - Current report
2024/05/16

重要事件披露

Form 8-K - Current report